LEADER 01143nam0-2200373-i-450- 001 990009115400403321 005 20091111145012.0 010 $a978-3-642-02546-4 035 $a000911540 035 $aFED01000911540 035 $a(Aleph)000911540FED01 035 $a000911540 100 $a20091111d2009----km-y0itay50------ba 101 0 $aeng 102 $aDE 105 $aa---a---001yy 200 1 $aContinuous-time Markov decision processes$etheory and applications$fXianping Guo, Onésimo Hernández-Lerma 210 $aBerlin$cSpringer$dc2009 215 $aXVII, 231 p.$d24 cm 225 1 $aStochastic modelling and applied probability$v62 610 0 $aProcessi decisionali Markoviani e semi-Markoviani 610 0 $aControllo stocastico ottimale 676 $a519$v21$zita 700 1$aGuo,$bXianping$0472387 701 1$aHernandez-Lerma,$bOnésimo$0350131 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009115400403321 952 $aC-39-(62$b24022$fMA1 959 $aMA1 962 $a90C40 962 $a93E20 996 $aContinuous-time Markov decision processes$9781614 997 $aUNINA LEADER 01474nam2-22004451i-450- 001 990000015510203316 010 $a92-4-154462-7 035 $a0001551 035 $aUSA010001551 035 $a(ALEPH)000001551USA01 035 $a0001551 100 $a20011108d--------km-y0ITAy01------ba 101 $aeng 102 $aCH 105 $a||||||||001yy 200 1 $aTests, methods, and general requirements, quality specifications for pharmaceutical substances, excipients, and dosage forms 210 $aGeneva$cWorld Health organization$c1994 215 $aXV, 343 p. 461 $10010072563$12001$aThe international pharmacopoeia 606 0 $aFarmacopea 676 $a615.11 912 $a990000015510203316 951 $a615.11 INT 4$b2005 Farm$c615.11 959 $aBK 969 $aFAR 979 $c20000914$lUSA01$h1708 979 $c20001019$lUSA01$h1053 979 $c20001019$lUSA01$h1451 979 $c20001019$lUSA01$h1458 979 $c20001019$lUSA01$h1536 979 $c20001024$lUSA01$h1511 979 $c20001027$lUSA01$h1516 979 $c20001027$lUSA01$h1520 979 $c20001110$lUSA01$h1708 979 $c20001124$lUSA01$h1205 979 $aPATTY$b90$c20011108$lUSA01$h1723 979 $c20020403$lUSA01$h1609 979 $aPATRY$b90$c20040406$lUSA01$h1603 996 $aTests, methods, and general requirements, quality specifications for pharmaceutical substances, excipients, and dosage forms$91488603 997 $aUNISA